United States · FDA National Drug Code directory

Desvenlafaxine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1815_7872f7a6-43f9-4ec4-9cc1-0bf90af847ed
Product NDC
71335-1815
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Desvenlafaxine
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20200801
Source listing expiry
20271231

Source-listed ingredients

  • DESVENLAFAXINE SUCCINATE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1815-1) · 71335-1815-1
  • 28 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1815-2) · 71335-1815-2
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1815-3) · 71335-1815-3
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-1815-4) · 71335-1815-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →